Market research
INVO INVO Bioscience Inc
NASDAQ USD Healthcare
Latest close
As of 21 Jan 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3M
- P/E ratio
- 1.21
- Analyst target
- 20
- Dividend yield
- Not available
- Beta
- 1.44
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 3M
- P/E ratio
- 1.21
- Analyst target
- 20
- Dividend yield
- Not available
- Beta
- 1.44
About
About INVO Bioscience Inc
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Research context
INVO Bioscience Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the INVO discussion.
5 years, 7 months ago
From a valuation standpoint, the stock is 97.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 39.0.
Based on the above factors, INVO Bioscience, Inc gets an overall score of 1/5.